172 related articles for article (PubMed ID: 23409030)
21. ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways.
Lin SL; Yan LY; Zhang XT; Yuan J; Li M; Qiao J; Wang ZY; Sun QY
PLoS One; 2010 Feb; 5(2):e9013. PubMed ID: 20126312
[TBL] [Abstract][Full Text] [Related]
22. bcl-2 induction of urokinase plasminogen activator receptor expression in human cancer cells through Sp1 activation: involvement of ERK1/ERK2 activity.
Trisciuoglio D; Iervolino A; Candiloro A; Fibbi G; Fanciulli M; Zangemeister-Wittke U; Zupi G; Del Bufalo D
J Biol Chem; 2004 Feb; 279(8):6737-45. PubMed ID: 14660675
[TBL] [Abstract][Full Text] [Related]
23. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
[TBL] [Abstract][Full Text] [Related]
24. Nongenomic effect of estrogen on the MAPK signaling pathway and calcium influx in endometrial carcinoma cells.
Zhang L; Li X; Zhao L; Zhang L; Zhang G; Wang J; Wei L
J Cell Biochem; 2009 Mar; 106(4):553-62. PubMed ID: 19160418
[TBL] [Abstract][Full Text] [Related]
25. Mitogen-activated protein kinase cascade-mediated histone H3 phosphorylation is critical for telomerase reverse transcriptase expression/telomerase activation induced by proliferation.
Ge Z; Liu C; Björkholm M; Gruber A; Xu D
Mol Cell Biol; 2006 Jan; 26(1):230-7. PubMed ID: 16354694
[TBL] [Abstract][Full Text] [Related]
26. Crosstalk between estrogen receptor and mitogen-activated protein kinase signaling in the development and progression of endometrial cancer.
Zhou L; Cai B; Bao W; He YY; Chen XY; Yang YX; Liu XL; Wan XP
Int J Gynecol Cancer; 2011 Nov; 21(8):1357-65. PubMed ID: 21720253
[TBL] [Abstract][Full Text] [Related]
27. [Membrane-initiated nongenomic effect on mitogen-activated protein kinase signal transduction of estrogen in endometrial carcinoma cell].
Zhang LL; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):615-8. PubMed ID: 19087499
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis.
Lobenhofer EK; Huper G; Iglehart JD; Marks JR
Cell Growth Differ; 2000 Feb; 11(2):99-110. PubMed ID: 10714766
[TBL] [Abstract][Full Text] [Related]
29. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
Vivacqua A; Bonofiglio D; Recchia AG; Musti AM; Picard D; Andò S; Maggiolini M
Mol Endocrinol; 2006 Mar; 20(3):631-46. PubMed ID: 16239258
[TBL] [Abstract][Full Text] [Related]
30. Adaptive hypersensitivity following long-term estrogen deprivation: involvement of multiple signal pathways.
Yue W; Wang JP; Conaway MR; Li Y; Santen RJ
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):265-74. PubMed ID: 14623520
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor-alpha and endothelial nitric oxide synthase nuclear complex regulates transcription of human telomerase.
Grasselli A; Nanni S; Colussi C; Aiello A; Benvenuti V; Ragone G; Moretti F; Sacchi A; Bacchetti S; Gaetano C; Capogrossi MC; Pontecorvi A; Farsetti A
Circ Res; 2008 Jul; 103(1):34-42. PubMed ID: 18519947
[TBL] [Abstract][Full Text] [Related]
32. Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells.
Misiti S; Nanni S; Fontemaggi G; Cong YS; Wen J; Hirte HW; Piaggio G; Sacchi A; Pontecorvi A; Bacchetti S; Farsetti A
Mol Cell Biol; 2000 Jun; 20(11):3764-71. PubMed ID: 10805720
[TBL] [Abstract][Full Text] [Related]
33. 17beta-Estradiol inhibits matrix metalloproteinase-2 transcription via MAP kinase in fibroblasts.
Mahmoodzadeh S; Dworatzek E; Fritschka S; Pham TH; Regitz-Zagrosek V
Cardiovasc Res; 2010 Mar; 85(4):719-28. PubMed ID: 19861308
[TBL] [Abstract][Full Text] [Related]
34. MAPK and JAK-STAT signaling pathways are involved in the oxidative stress-induced decrease in expression of surfactant protein genes.
Park SK; Dahmer MK; Quasney MW
Cell Physiol Biochem; 2012; 30(2):334-46. PubMed ID: 22739240
[TBL] [Abstract][Full Text] [Related]
35. Nongenomic estrogen effects on nitric oxide synthase activity in rat adipocytes.
Jaubert AM; Mehebik-Mojaat N; Lacasa D; Sabourault D; Giudicelli Y; Ribière C
Endocrinology; 2007 May; 148(5):2444-52. PubMed ID: 17303666
[TBL] [Abstract][Full Text] [Related]
36. Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the invasiveness of endometrial cancer cells through the GnRH-I receptor and mitogen-activated protein kinase (MAPK)-dependent activation of matrix metalloproteinase (MMP)-2.
Wu HM; Wang HS; Huang HY; Lai CH; Lee CL; Soong YK; Leung PC
BMC Cancer; 2013 Jun; 13():300. PubMed ID: 23786715
[TBL] [Abstract][Full Text] [Related]
37. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
38. Estrogen activates telomerase.
Kyo S; Takakura M; Kanaya T; Zhuo W; Fujimoto K; Nishio Y; Orimo A; Inoue M
Cancer Res; 1999 Dec; 59(23):5917-21. PubMed ID: 10606235
[TBL] [Abstract][Full Text] [Related]
39. Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation.
Martin LA; Farmer I; Johnston SR; Ali S; Marshall C; Dowsett M
J Biol Chem; 2003 Aug; 278(33):30458-68. PubMed ID: 12775708
[TBL] [Abstract][Full Text] [Related]
40. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D
Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
